Navigation Links
Sagent Pharmaceuticals to Present at Piper Jaffray Health Care Conference
Date:11/23/2009

SCHAUMBURG, Ill., Nov. 23 /PRNewswire/ -- Sagent Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company with a focus on injectable products, today announced that Jeffery M. Yordon, chief executive officer, founder and chairman of the board of Sagent Pharmaceuticals, will present at the 21st Annual Piper Jaffray Health Care Conference on Tuesday, December 1, 2009 at 9:30am eastern time at the New York Palace Hotel in New York City, NY.

About Sagent Pharmaceuticals, Inc.

Sagent Pharmaceuticals, founded in 2006, is a privately held specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products. Sagent has created a unique, global network of resources, comprised of rapid development capabilities, sophisticated manufacturing and innovative drug-delivery technologies, quickly yielding an extensive portfolio of pharmaceutical products that fulfills the evolving needs of patients. Sagent currently has more than 200 products in development.

To Discover Injectables Excellence(TM) and learn more about Sagent, please visit www.SagentPharma.com.

SOURCE Sagent Pharmaceuticals, Inc.


'/>"/>
Copyright©2009 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Sagent Pharmaceuticals Announces Launch of Adenosine Injection, USP, in 6 mg per 2 mL Single-Dose Vials
2. Sagent Pharmaceuticals Launches Vinorelbine Injection, USP
3. Sagent Pharmaceuticals to Present at Two Upcoming Financial Conferences
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
6. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
10. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
11. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/24/2016)... Los innovadores de COMBO[TM], ... introduce catéteres para la intervención de extremidades inferiores ... global especializada en el suministro de soluciones vasculares ... incluyendo productos para tratar la enfermedad arterial periférica. ... los dispositivos de primera entrada de la compañía ...
(Date:5/24/2016)... AMSTERDAM , May 24, 2016 Dutch ... their best practices around the world and treat patients on a ... Africa , Asia and the ... streaming with instant messaging and networking in a totally secure environment. ... Frontieres in a war zone working together with a surgeon at ...
(Date:5/23/2016)... , May 23, 2016 ... across 163 pages, profiles 12 companies and the Paclitaxel ... and figures on the industry and its players. ... is comprehensive in nature, details the current state of ... industry including definitions, classifications, applications and industry chain structure. ...
Breaking Medicine Technology:
(Date:5/24/2016)... ... May 24, 2016 , ... Loma Linda University Health (LLUH) ... hospital and expanded Children’s Hospital. Over 3,000 people looked on as the shovels hit ... the event photo slidehsow. , During the program, Richard H. Hart, MD, DrPH, ...
(Date:5/24/2016)... ... 2016 , ... Boyd Industries, a leading supplier of dental chairs and ... for pediatric dentistry , at AAPD 2016, the annual conference and trade show ... Concealed Delivery Unit keeps dental hand pieces and other anxiety-provoking pieces of the dental ...
(Date:5/24/2016)... ... 24, 2016 , ... A newly released report reveals that improving life outcomes ... resources, both in face-to-face interactions and online. In “Heard, Not Judged – Insights into ... creative use of mobile digital devices can be an effective tool to help boys ...
(Date:5/24/2016)... ... May 24, 2016 , ... Growing in popularity, more and more people continue ... available and easily accessible. Whether someone chooses to cut gluten out of their life ... King Kullen Grocery stocks their shelves with many different gluten-free products all year round. ...
(Date:5/24/2016)... ... 24, 2016 , ... American Gene Technologies International, Inc ... its board of directors. Otterstatter is co-founder, president and CEO of Preventice, ... that lead to broad-based healthcare solutions. , “Jon knows how to create disruptive ...
Breaking Medicine News(10 mins):